featured stories
Representatives from Families First, Novocure and WJP Development of Portsmouth, New Hampshire celebrate Novocure’s $250,000 gift to support the new home of the Families First Health and Support Center.
the extra in the ordinary
Share stories of finding purpose and joy in simple moments while living with GBM.
you are not alone in a cancer diagnosis
Lean on patient advocacy groups for the support you need.
a Q&A with our founder
Novocure founder Professor Yoram Palti, recipient of the 2022 Israel Prize for excellence in entrepreneurship and technological innovation, reflects on his discovery of Tumor Treating Fields.
Novocure joins New Hampshire Life Sciences
We will work with industry partners to champion New Hampshire’s cutting-edge life sciences sector and improve patients’ lives.
Novocure pledges $250K to Families First Health and Support Center
Our donation will help turn a former gym in Portsmouth into a 15,000-square-foot community health center.
lighting the world blue
To raise mesothelioma awareness and honor everyone affected by this aggressive cancer, Novocure is leading an initiative called Light the World Blue. For the second consecutive year, we’ve arranged for buildings and landmarks in U.S. cities to light blue, the official color of mesothelioma awareness, on Sept. 26.
standing with the brain tumor community
As a global oncology company focusing on improving survival in some of the most aggressive forms of cancer, Novocure proudly stands with the brain tumor community during May for Brain Tumor Awareness Month (BTAM).
Ignace Vergote Novocure Clinical Trial Investigator
Professor Ignace Vergote has dedicated his 32-year career to investigating treatment options and striving to improve survival in gynecologic cancers. Among gynecologic cancers, ovarian cancer is the deadliest, representing the fifth most common cause of cancer death among women in the United States. Five-year survival in ovarian cancer has slowly increased from 34 percent in 1975 to 47 percent today.